Achieve Life Sciences (ACHV) Other Operating Expenses (2010 - 2026)

Achieve Life Sciences (ACHV) recorded quarterly Other Operating Expenses of $341000.0 in Q1 2026, up 610.42% on a QoQ basis from $48000.0 in Q4 2025.

Achieve Life Sciences (ACHV) Other Operating Expenses (2010 - 2026) Analysis & Trends

Achieve Life Sciences has disclosed Other Operating Expenses across 8 years of filings, most recently posting $341000.0 for Q1 2026.

Quarterly Other Operating Expenses changed N/A year-over-year to $341000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $389000.0 (changed N/A YoY) and the FY2025 annual result came in at $48000.0, changed N/A from the prior year.
Other Operating Expenses improved to $341000.0 in Q1 2026, from $48000.0 in the prior quarter.
Over five years, Other Operating Expenses peaked at $341000.0 in Q1 2026 and troughed at $48000.0 in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	762,369.55 Bn	762,369.51 Bn	-
2	Belite Bio	55,096.00 Bn	55,096.00 Bn	-
3	Quantum Biopharma	17,755.80 Bn	17,755.79 Bn	-
4	Legend Biotech	3,486.00 Bn	3,485.71 Bn	242.10 Mn
5	Akari Therapeutics	1,737.42 Bn	1,737.41 Bn	-
6	Evaxion A	1,551.28 Bn	1,551.26 Bn	-
7	Psyence Biomedical	227.32 Bn	227.31 Bn	-
8	Vertex Pharmaceuticals	110.84 Bn	103.59 Bn	2.59 Bn
9	Abivax	91.71 Bn	91.71 Bn	-
10	Achieve Life Sciences	93.71 Mn	63.22 Mn	-

Download Data